Curtis Lockshin Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Curtis Lockshin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Curtis Lockshin. Curtis Lockshin is Director in Sorrento Therapeutics, Inc. ($SRNE) and Chief Sciencific Officer in Xenetic Biosciences, Inc. ($XBIO) and Chief Scientific Officer in Xenetic Biosciences, Inc. ($XBIO) and Director in RXi Pharmaceuticals Corp ($RXII).
Latest Insider Trading Transactions of Curtis Lockshin
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, PHIO, SRNE, XBIO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22 2021 | XBIO | Xenetic Bioscience ... | Lockshin Curtis | Chief Sciencific Of ... | Option Exercise | A | 2.60 | 50,000 | 130,000 | 50,000 | |
| Mar 03 2021 | PHIO | Phio Pharmaceutica ... | Lockshin Curtis | Director | Grant | A | 0.00 | 10,000 | 0 | 10,366 | 366 to 10.4 K (+2,732.24 %) |
| Dec 06 2019 | XBIO | Xenetic Bioscience ... | Lockshin Curtis | Chief Scientific Of ... | Option Exercise | A | 1.31 | 90,000 | 117,900 | 90,000 | |
| Feb 15 2019 | RXII | Phio Pharmaceutica ... | Lockshin Curtis | Director | Grant | A | 0.00 | 10,000 | 0 | 20,130 | 10.1 K to 20.1 K (+98.72 %) |
| Aug 03 2018 | RXII | RXi Pharmaceutical ... | Lockshin Curtis | Director | Grant | A | 0.00 | 10,000 | 0 | 10,130 | 130 to 10.1 K (+7,692.31 %) |
| Feb 03 2017 | RXII | RXi Pharmaceutical ... | Lockshin Curtis | Director | Option Exercise | A | 0.63 | 2,000 | 1,258 | 2,000 | |
| Feb 12 2016 | RXII | RXi Pharmaceutical ... | Lockshin Curtis | Director | Option Exercise | A | 0.29 | 16,666 | 4,763 | 16,666 | |
| Jun 03 2015 | RXII | RXi Pharmaceutical ... | Lockshin Curtis | Director | Option Exercise | A | 0.52 | 6,000 | 3,120 | 6,000 | |
| Jun 03 2015 | RXII | RXi Pharmaceutical ... | Lockshin Curtis | Director | Option Exercise | A | 0.46 | 6,000 | 2,730 | 6,000 | |
| Jun 03 2015 | RXII | RXi Pharmaceutical ... | Lockshin Curtis | Director | Grant | A | 0.40 | 12,000 | 4,800 | 13,000 | 1,000 to 13 K (+1,200.00 %) |
| Jun 02 2015 | RXII | RXi Pharmaceutical ... | Lockshin Curtis | Director | Option Exercise | A | 0.38 | 16,666 | 6,333 | 16,666 | |
| Sep 22 2009 | SRNE | Sorrento Therapeut ... | Lockshin Curtis | Director | Option Exercise | A | 0.04 | 40,000 | 1,792 | 40,000 |
Page: 1